logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
S

Sumanta K. Pal

city of hope comprehensive cancer center
H指数:88
被引数:3.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

International multidisciplinary Delphi consensus on advanced practice in non-metastatic upper tract urothelial carcinoma (IMPACT UTUC)

国际多学科德尔菲共识：非转移性上尿路尿路上皮癌的先进实践（IMPACT UTUC）

Nature Reviews Urology
IF14.6
2026-11-110
PRE
Savio Domenico Pandolfo; Roberto Contieri; M. Carmen Mir; Peter C. Black; Alexander Kutikov; Daniele Amparore; Alessandro Antonelli; Riccardo Bertolo; Alessandro Veccia; Joyce Baard; Alberto Breda; Andrea Gallioli; Alberto Briganti; Marco Moschini; James W. Catto; Giuseppe Di Lorenzo; Matteo Ferro; Luigi Formisano; Saum Ghodoussipour; Guido Giusti; Paolo Gontero; Mark Gonzalgo; Petros Grivas; Ashish M. Kamat; Roger Li; Fredrik Liedberg; Estavao Lima; Jennifer Linehan; Giuseppe Lucarelli; Vitaly Margulis; Paramananthan Mariappan; Alberto Martini; Alexandra Masson-Lecomte; Wagner Matheus; Reza Mehrazin; Laura S. Mertens; Andrea Minervini; Andrea Mari; Andrea Necchi; Sumanta K. Pal; Kamol Panumatrassamee; Phillip M. Pierorazio; Sima Porten; James Porter; Benjamin Pradere; Sarah P. Psutka; Jay D. Raman; Morgan Roupret; Shahrokh Shariat; Giuseppe Simone; Nirmish Singla; Bhaskar K. Somani; Guru P. Sonpavde; Cora N. Sternberg; Michael Stifelman; Toshio Takagi; Hajime Tanaka; Jeremy YC Teoh; Bas W. G. van Rhijn; Marcelo L. Wroclawski; Zhenjie Wu; Evanguelos Xylinas; Homi Zargar; Stênio de Cássio Zequi; Rebecca A. Campbell; Christopher J. Weight; Sisto Perdonà; Francesco Porpiglia; Riccardo Campi; Clara Cerrato; Maria J. Ribal; Li-Ming Su; Randall Lee; Surena Matin; Shilpa Gupta; Laura Bukavina; Hooman Djaladat; Ithaar Derweesh; Riccardo Autorino
Comprehensive Genomic and Transcriptomic Characterization of Matched Primary and Recurrent Tumors in High-risk Localized Renal Cell Carcinoma

高-risk 局部肾细胞癌配对的原发和复发肿瘤的全面基因组学和转录组学特征

European Urology
IF25.2
2026-04-250
PRE
Wenxin Xu; Brian I. Rini; Laurence Albiges; Xiaobin Tang; Hartmut Koeppen; Axel Bex; Cristina Suárez; Robert Uzzo; Viraj Master; Jose A. Karam; Habib Hamidi; Zoe June Assaf; Sarita Dubey; Erik T. Goluboff; Corey Carter; Romain Banchereau; Mahrukh A. Huseni; Sumanta Kumar Pal
Attrition Rates in Metastatic Renal Cell Carcinoma (mRCC) Following First Line Immunotherapy-Based Treatment: Results From the International mRCC Database Consortium (IMDC)

在接受基于免疫治疗的一线治疗后转移性肾细胞癌（mRCC）中的患者流失率：来自国际mRCC数据库联盟（IMDC）的结果

Clinical Genitourinary Cancer
IF2.7
2026-01-010
PRE
Lemelin, Audreylie; Zarba, Martin; Takemura, Kosuke; Wells, J. Connor; Chehade, Razane El Hajj; Donskov, Frede; Porta, Camillo; De Velasco, Guillermo; Davis, Ian D.; Wood, Lori A.; Pal, Sumanta K.; Hansen, Aaron R.; Tran, Ben; Bjarnason, Georg A.; Li, Haoran; Kanesvaran, Ravindran; Powles, Thomas; Mckay, Rana R.; Choueiri, Toni K.; Heng, Daniel Y. C.
Clinical Predictors and Prognostic Significance of Pathologic Disease Upstaging at Radical Cystectomy in Patients with Muscle-Invasive Bladder Cancer

肌层浸润性膀胱癌患者根治性膀胱切除术中病理疾病升级的临床预测因素及预后意义

Cancers 2025, Vol. 17, Page 3265
IF0
2025-10-090
OA
Salvador Jaime-Casas; Wesley Yip; Daniel J. Lama; Vitor Goes; Miguel Zugman; Koral Shah; Regina Barragan-Carrillo; Hedyeh Ebrahimi; Daniela V. Castro; Yu Jun Li; Benjamin Mercier; JoAnn Hsu; Xiaochen Li; Clayton S. Lau; Kevin G. Chan; Bertram E. Yuh; Alexander Chehrazi-Raffle; Sumanta K. Pal; Abhishek Tripathi
Efficacy and safety of antibody-drug conjugate combination therapy in advanced urothelial carcinoma

抗体药物偶联物联合疗法在晚期尿路上皮癌中的疗效与安全性

Frontiers in Oncology
IF3.3
2025-10-070
OAAI
Salvador Jaime-Casas; Regina Barragan-Carrillo; Miguel Zugman; Koral Shah; Hedyeh Ebrahimi; Benjamin Mercier; Daniela V. Castro; Peter D. Zang; Alexis LeVee; Wesley Yip; Xiaochen Li; Nazli Dizman; Nicholas J. Salgia; Zeynep Zengin; Luis Meza; JoAnn Hsu; Charles B. Nguyen; Alexander Chehrazi-Raffle; Sumanta K. Pal; Abhishek Tripathi
Subgroup analysis of the efficacy and safety of cabozantinib ± atezolizumab in patients from CONTACT-03 who received first-line treatment with immuno-oncology-based combinations

卡博替尼±阿替利珠单抗在CONTACT-03研究中接受以免疫肿瘤为基础的联合方案一线治疗患者的疗效和安全性亚组分析

ONCOLOGIST
IF4.2
2025-10-010
OAAI
Mcgregor, Bradley A.; Suarez, Cristina; Choueri, Toni; Albiges, Laurence; Voss, Martin; Khan, Omara; Williamson, Denise; Ricardo Perez, Jose; Hall, Tasha; Pal, Sumanta
Exploring Health-Related quality of life across the disease spectrum in renal cell carcinoma: a conceptual domain analysis

探索肾细胞癌疾病谱中健康相关生命质量的领域分析

ONCOLOGIST
IF4.2
2025-10-010
OA
Shah, Koral; Bergerot, Paulo Gustavo; Castro, Daniela; Mercier, Benjamin; Nally, Elizabeth; Ali, Adil; Hutson, Thomas E.; Bex, Axel; Psutka, Sarah P.; Rini, Brian; Plimack, Elizabeth; Master, Viraj A.; Grunwald, Viktor; Albiges, Laurence; Choueri, Toni; Pal, Sumanta; Cella, David; Powles, Thomas; Bergerot, Cristiane Decat
Lower checkpoint gene expression is associated with primary resistance to nivolumab-ipilimumab combination in advanced renal cell carcinoma

低检查点基因表达与晚期肾细胞癌对纳武利尤单抗-伊匹木单抗联合治疗的原发耐药相关

ONCOLOGIST
IF4.2
2025-10-010
OAAI
McKay, Rana; Dugan, Adam; Jariwala, Unnati; Ronski, Karyn; Mercer, Jacob; Saad, Eddy; El Masri, Jad; Machaalani, Marc; Saleh, Mustafa; Rose, Cody; Sun, Maxine; Signoretti, Sabina; Braun, David; Pal, Sumanta; Choueri, Toni
Characterization of aberrant alternative splicing landscape in patients with metastatic renal cell carcinoma

转移性肾细胞癌患者中异常替代剪接景观的特征分析

ONCOLOGIST
IF4.2
2025-10-010
OAAI
Mercier, Benjamin; Govindarajan, Ameish; Hansen, Nathaniel; Byron, Sara; Hegde, Apurva; Leskoske, Kristin; Chawla, Neal; Meza, Luis; Zengin, Zeynep; Barragan-Carrillo, Regina; Ebrahimi, Hedyeh; Castro, Daniela; Jaime-Casas, Salvador; Zugman, Miguel; Dizman, Nazli; Hsu, JoAnn; Chehrazi-Raffle, Alexander; Tripathi, Abhishek; Salgia, Nicholas; Pal, Sumanta; Pirrotte, Patrick
Real-World efficacy and safety of belzutifan in sporadic metastatic renal cell carcinoma: a multicenter study from the city of hope enterprise

belzutifan在散发性转移性肾细胞癌中的真实世界有效性与安全性：一项来自City of Hope Enterprise的多中心研究

ONCOLOGIST
IF4.2
2025-10-010
OAAI
Nguyen, Charles; Nguyen, Kim; Ebrahimi, Hedyeh; Zugman, Miguel; Zang, Peter; Pisick, Evan; Kollimuttathuillam, Sudarsan; Mehta, Nilesh; Liu, Sandy; Tripathi, Abhishek; Chehrazi-Raffle, Alexander; Adesunloye, Bamidele; Bryce, Alan; Dorff, Tanya; Pal, Sumanta
Clinical characteristics, determinants and subsequent therapy of primary refractory metastatic renal cell carcinoma (mRCC): an international metastatic database consortium (IMDC) study

原发性难治性转移性肾细胞癌（mRCC）的临床特征、决定因素及后续治疗：一项国际转移数据库联盟（IMDC）研究

ONCOLOGIST
IF4.2
2025-10-010
OAAI
Eid, Marc; Semaan, Karl; Xie, Wanling; Chehade, Razane El Hajj; Ascione, Liliana; Maj, David; Zarba, Martin; Wells, J. Connor; Wood, Laura; Tran, Ben; Angel, Martin; Pal, Sumanta K.; Lee, Jae-Lyun; Takemura, Kosuke; Kollmannsberger, Christian K.; Templeton, Arnoud J.; Bjarnason, Georg A.; Ruiz, Jose Manuel; Heng, Daniel; Choueiri, Toni K.

研究方向

暂未获取到该数据
T
Toni K. Choueiri
H 指数:149论文数:2,479被引数:12.7万
U
Ulka N. Vaishampayan
H 指数:74论文数:1,101被引数:2.5万
N
Nazlı Dizman
H 指数:24论文数:233被引数:2,624
P
Paulo Gustavo Bergerot
H 指数:20论文数:175被引数:2,032
N
Neeraj Agarwal
H 指数:6论文数:45被引数:637
N
Neeraj Agarwal
H 指数:48论文数:454被引数:1.3万
L
Luís Meza
H 指数:25论文数:215被引数:3,462
B
Brian I. Rini
H 指数:122论文数:1,339被引数:7.7万
C
Cristiane Decat Bergerot
H 指数:21论文数:264被引数:2,235
F
Frede Donskov
H 指数:62论文数:369被引数:2.9万